Follow
Emyr Bakker
Emyr Bakker
Senior Lecturer - Physician Associate Programme, University of Central Lancashire
Verified email at uclan.ac.uk - Homepage
Title
Cited by
Cited by
Year
The role of microenvironment and immunity in drug response in leukemia
E Bakker, M Qattan, L Mutti, C Demonacos, M Krstic-Demonacos
Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1863 (3), 414-426, 2016
962016
BAP1 Status Determines the Sensitivity of Malignant Mesothelioma Cells to Gemcitabine Treatment
A Guazzelli, P Meysami, E Bakker, C Demonacos, A Giordano, ...
International Journal of Molecular Sciences 20 (2), 429, 2019
492019
Anti-CTLA-4 therapy for malignant mesothelioma
A Guazzelli, E Bakker, M Krstic-Demonacos, MP Lisanti, F Sotgia, L Mutti
Immunotherapy 9 (3), 273-280, 2017
262017
Promising investigational drug candidates in phase I and phase II clinical trials for mesothelioma
A Guazzelli, E Bakker, K Tian, C Demonacos, M Krstic-Demonacos, ...
Expert opinion on investigational drugs 26 (8), 933-944, 2017
172017
p53 modeling as a route to mesothelioma patients stratification and novel therapeutic identification
K Tian, E Bakker, M Hussain, A Guazzelli, H Alhebshi, P Meysami, ...
Journal of translational medicine 16, 1-15, 2018
152018
Immunotherapy advances for mesothelioma treatment
E Bakker, A Guazzelli, F Ashtiani, C Demonacos, M Krstic-Demonacos, ...
Expert review of anticancer therapy 17 (9), 799-814, 2017
152017
Current and prospective pharmacotherapies for the treatment of pleural mesothelioma
E Bakker, A Guazzelli, M Krstic-Demonacos, M Lisanti, F Sotgia, L Mutti
Expert Opinion on Orphan Drugs 5 (6), 455-465, 2017
112017
Insight into glucocorticoid receptor signalling through interactome model analysis
E Bakker, K Tian, L Mutti, C Demonacos, JM Schwartz, ...
PLoS computational biology 13 (11), e1005825, 2017
102017
The use of multi-omics data and approaches in breast cancer immunotherapy: A review
KL Leung, D Verma, YJ Azam, E Bakker
Future Oncology 16 (27), 2101-2119, 2020
92020
Differential regulation of cell death pathways by the microenvironment correlates with chemoresistance and survival in leukaemia
MY Qattan, EY Bakker, R Rajendran, DWC Chen, V Saha, J Liu, L Zeef, ...
PloS one 12 (6), e0178606, 2017
72017
Protein disulfide isomerase A1‑associated pathways in the development of stratified breast cancer therapies
EY Bakker, M Fujii, M Krstic‑Demonacos, C Demonacos, R Alhammad
International Journal of Oncology 60 (2), 1-19, 2022
62022
What can independent research for mesothelioma achieve to treat this orphan disease?
A Guazzelli, P Meysami, E Bakker, E Bonanni, C Demonacos, ...
Expert Opinion on Investigational Drugs 28 (8), 719-732, 2019
62019
Molecular mechanisms of PD-1 and PD-L1 activity on a pan-cancer basis: A bioinformatic exploratory study
S Kannan, GM O’Connor, EY Bakker
International Journal of Molecular Sciences 22 (11), 5478, 2021
52021
Antitumor effects of a recombinant baculovirus displaying anti-HER2 scFv expressing Apoptin in HER2 positive SK-BR-3 breast cancer cells
P Meysami, F Rezaei, SM Marashi, MM Amiri, E Bakker, T Mokhtari-Azad
Future Virology 14 (3), 139-152, 2019
52019
Intratumor microbiota as a novel potential prognostic indicator in mesothelioma
F Pentimalli, M Krstic-Demonacos, C Costa, L Mutti, E Bakker
Frontiers in Immunology 14, 1195, 2023
12023
Patient-level omics data analysis identifies gene-specific survival associations for a PD-1/PD-L1 network in pleural mesothelioma
GM O’Connor, EY Bakker
BioMedInformatics 2 (4), 580-592, 2022
12022
A 4-Year Undergraduate Route to UK Physician Associate qualification
EY Bakker, J Rutt-Howard, R Norris
The Journal of Physician Assistant Education 34 (3), 260-264, 2023
2023
Exploring a Link Between Alzheimer’s and Glioma by Investigating SORL1 Network
MK Montalbo, E Bakker, I Stasik, C Smith
Neuro-Oncology 24 (Suppl 4), iv22, 2022
2022
Bioinformatics and clinic: predictive models in cancer patients stratification and novel therapies identification
K Tian, E Bakker, M Hussain, H Alhebshi, P Meysami, C Demonacos, ...
24th World Congress on Advances in Oncology & 24th International Symposium …, 2019
2019
The Treatment of Malignant Pleural Mesothelioma: From the Current Standard to Novel Possible Therapeutic Strategies
E Bakker, A Guazzelli, C Demonacos, M Krstic-Demonacos, L Mutti
Malignant Pleural Mesothelioma, 117-136, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–20